COGT
Cogent Biosciences·NASDAQ
--
--(--)
--
--(--)
6.27 / 10
Outperform
Capital flow assessment yields 7.67/10, denoting robust fund flow characteristics. Strengths in overall, block, Medium, Large, and Extra-large trends confront pressures from Small patterns, resulting in positive liquidity outlook. Analyst sentiment reflects overwhelmingly bullish analyst consensus with strong conviction. The rating profile includes Strong Buy(50.0%), Buy(50.0%) from 2 analytical reports, supported by 4.86 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-21
InstitutionWedbush
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of COGT?
- COGT holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.27/10 (Outperform).
